Technical Analysis for OPHLF - Ono Pharmaceutical

Grade Last Price % Change Price Change
grade F 18.0 0.00% 0.0000
OPHLF closed unchanged on Monday, July 6, 2020, on 44 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical OPHLF trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Gapped Down Weakness 0.00%
Volume Surge Other -2.06%
Narrow Range Bar Range Contraction -2.06%
Gapped Up Strength -2.06%
Volume Surge Other 0.46%
Narrow Range Bar Range Contraction 0.46%
Gapped Down Weakness 0.46%
Older signals for OPHLF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Ono Pharmaceutical Co., Ltd. produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. The company's products include OPDIVO intravenous infusions for treating malignant tumor; KYPROLIS, a proteasome inhibitor for intravenous injection; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Glactiv and FORXIGA tablets for type II diabetes; Kinedak tablets to treat diabetic peripheral neuropathy; Recalbon tablets to treat osteoporosis; ORENCIA injections for rheumatoid arthritis; Rivastach patches for Alzheimer's disease treatment; Onoact injections for treating tachyarrhythmia; Staybla tablets for overactive bladder; Opalmon tablets to treat peripheral circulatory disorder; Onon capsules and dry syrups for treating bronchial asthma and allergic rhinitis; and Foipan tablets for treating chronic pancreatitis and postoperative reflux esophagitis. It is also developing products for gastric, colorectal, small and non-small cell lung, head and neck, urothelial, esophageal, ovarian, biliary tract, hematologic cancers; and hodgkin lymphoma, hepatocellular carcinoma, glioblastoma, malignant pleural mesothelioma, multiple myeloma, diffuse large B cell lymphoma, follicular lymphoma, solid tumor, central nervous system lymphoma, primary testicular lymphoma, virus positive/negative solid carcinoma, chronic myeloid leukemia, cancer anorexia/cachexia, melanoma, pheochromocytoma, acute leukemia, juvenile idiopathic arthritis, lupus nephritis, untreated rheumatoid arthritis, primary sjögren syndrome, polymyositis/dermatomyositis, chronic heart failure, tachyarrhythmia, ventricular arrhythmia, sepsis, hepatitis C, parkinson's disease, overactive bladder, osteoarthritis, sjögren syndrome, and underactive bladder. Ono Pharmaceutical Co., Ltd. has collaboration agreements with Eisai Co., Ltd. and Schrödinger Inc., Fate Therapeutics, Inc., and Merus N.V. The company was founded in 1717 and is headquartered in Osaka, Japan.
Medicine RTT Cancer Pharmaceuticals Clinical Medicine Chemotherapy Oncology Parkinson's Disease Osteoporosis Osteoarthritis Rheumatoid Arthritis Alzheimer's Disease Hematology Melanoma Multiple Myeloma Glioblastoma Hepatitis C Hepatocellular Carcinoma Lymphoma Anatomical Pathology Sepsis Allergic Rhinitis Vomiting Chronic Heart Failure Ii Diabetes Overactive Bladder Solid Tumor Acute Leukemia Chemotherapy Induced Nausea Chronic Pancreatitis Juvenile Idiopathic Arthritis Sjögren Syndrome

Is OPHLF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 28.83
52 Week Low 17.3
Average Volume 4,128
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.0000
10-Day Moving Average 21.0256
Average True Range 2.0787
ADX 0.0
+DI 43.6184
-DI 56.3813
Chandelier Exit (Long, 3 ATRs ) 22.5939
Chandelier Exit (Short, 3 ATRs ) 23.5361
Upper Bollinger Band 0.0000
Lower Bollinger Band 0.0000
Percent B (%b) 0.0
BandWidth 0.0000
MACD Line -1.0652
MACD Signal Line -0.4650
MACD Histogram -0.6002
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.0000
Resistance 3 (R3) 18.0000 18.0000 18.0000
Resistance 2 (R2) 18.0000 18.0000 18.0000 18.0000
Resistance 1 (R1) 18.0000 18.0000 18.0000 18.0000 18.0000
Pivot Point 18.0000 18.0000 18.0000 18.0000 18.0000
Support 1 (S1) 18.0000 18.0000 18.0000 18.0000 18.0000
Support 2 (S2) 18.0000 18.0000 18.0000 18.0000
Support 3 (S3) 18.0000 18.0000 18.0000
Support 4 (S4) 18.0000